YOLFTbeta
Dynavox Group

Dynavox Group

DYVOX · ST · Healthcare / Medical Instruments & Supplies

75.15SEK+1.40 (+1.90%)

Price History

Full chart

Market Stats

Previous Close73.75
Open73.75
Day Range73.00 – 76.65
52-Week Range57.20 – 108.25
Volume343.22K
Market Cap8.24B
P/E (TTM)36.63
Forward P/E0.00
EPS2.12
Dividend Yield0.65%
Beta0.81
50-Day Avg74.66
200-Day Avg80.58

About

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its communication solutions include language, software, hardware, funding, support, and training. The company operates in Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand. The company was formerly known as Tobii Dynavox AB (publ) and changed its name to Dynavox Group AB (publ) in July 2024. Dynavox Group AB (publ) was incorporated in 2012 and is headquartered in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Fredrik Ruben M.D.
  • Employees1.08K
  • HeadquartersLöjtnantsgatan 25, Stockholm, Sweden, 115 50, Sweden
  • Websitehttps://www.dynavoxgroup.com

Leadership

  • Mr. Fredrik Ruben M.D.Chief Executive Officer · b. 1977
  • Mr. Jacob ThordenbergChief Financial Officer · b. 1985
  • Mr. Luis MustafaChief Operating Officer · b. 1978
  • Ms. Marie-Josée LeblondChief Digitalization & Information Officer · b. 1968
  • Ms. Elisabeth ManziCorporate Communications Director
  • Ms. Kristen CookChief Marketing Officer · b. 1979
  • Mr. Mikael BackstromChief People & Sustainability Officer · b. 1968
  • Mr. Nils NormellPresident of Europe & the rest of the world -EUROW · b. 1964
  • Ms. Tara RudnickiPresident of North America · b. 1966
  • Mr. Markus CederlundChief Product & Development Officer · b. 1976

Financials

Income Statement

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue908.80M895.20M871.20M1.22B1.61B1.97B2.47B
Growth (%)--1.50%-2.68%+39.61%+32.64%+22.24%+25.10%
Cost of Revenue315.20M303.50M301.00M428.50M518.90M615.90M778.80M
Gross Profit593.60M591.70M570.20M787.80M1.09B1.36B1.69B
Gross Margin65.32%66.10%65.45%64.77%67.84%68.77%68.43%
Operating Expense492.60M464.50M510.20M705.50M944.70M1.13B1.43B
Operating Income101.00M127.20M60.00M82.30M149.70M228.60M254.10M
Operating Margin11.11%14.21%6.89%6.77%9.28%11.59%10.30%
EBITDA120.70M156.30M88.90M103.80M203.40M425.10M476.50M
EBITDA Margin13.28%17.46%10.20%8.53%12.61%21.56%19.31%
Net Income67.70M129.80M29.80M48.60M104.10M145.80M165.70M
Net Income Margin7.45%14.50%3.42%4.00%6.45%7.39%6.72%
R&D121.30M108.60M117.30M138.40M163.50M183.90M245.00M
R&D as % of Total Revenue13.35%12.13%13.46%11.38%10.13%9.33%9.93%
Interest Expense23.40M22.40M19.40M21.70M39.90M48.20M41.50M
Interest Expense % of Total Revenue2.57%2.50%2.23%1.78%2.47%2.44%1.68%

Balance Sheet

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets778.20M778.20M1.15B1.32B1.70B2.00B2.47B
Total Liabilities748.80M748.80M1.01B1.11B1.39B1.54B1.87B
Total Equity29.40M29.40M139.50M210.60M297.80M453.70M602.40M
Cash172.70M172.70M197.30M106.80M160.60M133.50M194.70M
Total Debt416.10M416.10M606.70M628.30M773.30M790.80M1.10B
Net Debt243.40M243.40M409.40M521.50M612.70M657.30M909.00M

Cash Flow

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow184.70M272.50M136.50M96.20M277.40M282.50M196.60M
Investing Cash Flow-108.60M-102.00M-370.30M-197.20M-296.90M-280.70M-316.40M
Financing Cash Flow-77.60M-39.60M253.10M2.50M78.40M-37.20M198.20M
Capital Expenditure108.60M102.00M367.30M118.20M134.50M183.10M204.90M
Free Cash Flow76.10M170.50M-230.80M-22.00M142.90M99.40M-8.30M
FCF to OCF41.20%62.57%-169.08%-22.87%51.51%35.19%-4.22%

Earnings

Report DateMar 2, 2022Apr 27, 2022Jul 21, 2022Oct 28, 2022Feb 8, 2023Apr 26, 2023Jul 20, 2023Oct 27, 2023Feb 8, 2024Apr 23, 2024Jul 18, 2024Oct 23, 2024Feb 5, 2025Apr 25, 2025Jul 18, 2025Oct 23, 2025Feb 5, 2026Apr 24, 2026Jul 22, 2026Oct 21, 2026
EPS Estimate---0.100.200.100.100.20-0.300.300.400.50-0.301.001.000.500.600.76
EPS Actual0.050.090.060.150.160.070.160.330.420.100.340.430.510.230.270.350.710.350.69-
Surprise---50.00%-20.00%-30.00%60.00%65.00%--66.67%13.33%7.50%2.00%--10.00%-65.00%-29.00%-30.00%15.00%-
Timing---Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap8.24B
Enterprise Value9.03B
Trailing P/E36.63
Forward P/E0.00
Price / Sales3.24
Price / Book10.95
EPS2.12
Book Value6.62
Revenue (TTM)2.54B
Gross Profit (TTM)1.75B
EBITDA464.10M
Profit Margin8.85%
Operating Margin15.67%
Return on Equity37.17%
Return on Assets9.49%
Shares Outstanding106.07M
Shares Float101.37M
Beta0.81
Dividend Yield0.65%
Dividend Rate0.50
Payout Ratio23.81%

Dividends

20261×
0.50May 11, 2026